MiMedx Group Inc.
8.60
0.04 (0.47%)
At close: Jan 14, 2025, 3:59 PM
8.21
-4.48%
Pre-market Jan 15, 2025, 07:14 AM EST
undefined%
Bid 8.2
Market Cap 1.26B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 0.57
PE Ratio (ttm) 15.08
Forward PE n/a
Analyst Buy
Ask 8.5
Volume 583,323
Avg. Volume (20D) 827,147
Open 8.60
Previous Close 8.56
Day's Range 8.54 - 8.66
52-Week Range 5.47 - 10.14
Beta undefined

About MDXG

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its produc...

Industry Biotechnology
Sector Healthcare
IPO Date Feb 12, 2008
Employees 895
Stock Exchange NASDAQ
Ticker Symbol MDXG

Analyst Forecast

According to 5 analyst ratings, the average rating for MDXG stock is "Buy." The 12-month stock price forecast is $11.5, which is an increase of 33.80% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

MiMedx Group Inc. is scheduled to release its earnings on Feb 26, 2025, during market hours.
Analysts project revenue of $87.64M, reflecting a 0.93% YoY growth and earnings per share of 0.06, making a 50.00% increase YoY.
2 months ago · Source
+23.56%
MiMedx Group shares are trading higher after the c... Unlock content with Pro Subscription
2 months ago · Source
+20.39%
MiMedx Group shares are trading higher after the company reported better-than-expected Q3 financial results.